Contributions of Rad9 to tumorigenesis

Journal of Cellular Biochemistry

Volumn 113, Issue 3, 2012, Pages 742-751

  Broustas, Constantinos G ^a   Lieberman, Howard B ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Columbia University ^*  (United States)

Author keywords

Cell Cycle Checkpoint; Dna Repair; Oncogene; Rad9; Tumor Suppressor

Indexed keywords

ALKYLATING AGENT; EXODEOXYRIBONUCLEASE III; EXODEOXYRIBONUCLEASE V; PROTEIN RAD9;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE CHECKPOINT; COMPLEX FORMATION; DNA REPAIR; ENZYME ACTIVITY; GENOMIC INSTABILITY; HUMAN; LUNG CANCER; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SKIN CANCER; STOMACH CANCER; TELOMERE; THYROID CANCER; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; DNA REPAIR; HUMANS; MICE; TRANSCRIPTION FACTORS;

EID: 84857622879     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23424     Document Type: Article

References (99)

1. An L, Wang Y, Liu Y, Yang X, Liu C, Hu Z, He W, Song W, Hang H. 2010. Rad9 is required for B cell proliferation and immunoglobulin class switch recombination. J Biol Chem 285:35267-35273.
2. Bai H, Madabushi A, Guan X, Lu AL. 2010. Interaction between human mismatch repair recognition proteins and checkpoint sensor Rad9-Rad1-Hus1. DNA Repair (Amst) 9:9478-9487.
3. Balakrishnan L, Brandt PD, Lindsey-Boltz LA, Sancar A, Bambara RA. 2009. Long patch base excision repair proceeds via coordinated stimulation of the multienzyme DNA repair complex. J Biol Chem 284:15158-15172.
4. Bao S, Lu T, Wang X, Zheng H, Wang LE, Wei Q, Hittelman WN, Li L. 2004. Disruption of the Rad9/Rad1/Hus1 (9-1-1) complex leads to checkpoint signaling and replication defects. Oncogene 23:5586-5593. (Pubitemid 39093036)
5. Bessho T, Sancar A. 2000. Human DNA damage checkpoint protein hRAD9 is a 3' to 5' exonuclease. J Biol Chem 275:7451-7454. (Pubitemid 30159636)
6. Bin Hafeez B, Adhami VM, Asim M, Siddiqui IA, Bhat KM, Zhong W, Saleem M, Din M, Setaluri V, Mukhtar H. 2009. Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res 15:452-459.
7. Cai RL, Yan-Neale Y, Cueto MA, Xu H, Cohen D. 2000. HDAC1, a histone deacetylase, forms a complex with Hus1 and Rad9, two G2/M checkpoint Rad proteins. J Biol Chem 275:27909-27916.
8. Chan V, Khoo US, Wong MS, Lau K, Suen D, Li G, Kwong A, Chan TK. 2008. Localization of hRad9 in breast cancer. BMC Cancer 8:196.
9. Chang DY, Lu AL. 2005. Interaction of checkpoint proteins Hus1/Rad1/Rad9 with DNA base excision repair enzyme MutY homolog in fission yeast, Schizosaccharomyces pombe. J Biol Chem 280:408-417.
10. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB. 2011. NF-kB addiction and its role in cancer: 'one size does not fit all'. Oncogene 30:1615-1630.
11. Chen MJ, Lin YT, Lieberman HB, Chen G, Lee EY. 2001. ATM-dependent phosphorylation of human Rad9 is required for ionizing radiation-induced checkpoint activation. J Biol Chem 276:16580-16586.
12. Cheng CK, Chow LW, Loo WT, Chan TK, Chan V. 2005. The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer. Cancer Res 65:8646-8654. (Pubitemid 41377351)
13. Ciccia A, Elledge SJ. 2010. The DNA damage response: Making it safe to play with knives. Mol Cell 40:179-204.
14. Cotta-Ramusino C, McDonald ER 3rd, Hurov K, Sowa ME, Harper JW, Elledge SJ. 2011. A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling. Science 332:1313-1317.
15. Delacroix S, Wagner JM, Kobayashi M, Yamamoto K, Karnitz LM. 2007. The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1. Genes Dev 21:1472-1477. (Pubitemid 46955719)
16. Demehri S, Turkoz A, Kopan R. 2009. Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell 16:55-66.
17. Devgan V, Mammucari C, Millar SE, Brisken C, Dotto GP. 2005. p21WAF1/ Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev 19:1485-1495. (Pubitemid 41003015)
18. Ellsworth RE, Ellsworth DL, Patney HL, Deyarmin B, Love B, Hooke JA, Shriver CD. 2008. Amplification of HER2 is a marker for global genomic instability. BMC Cancer 8:297.
19. Fan R, Kumaravel TS, Jalali F, Marrano P, Squire JA, Bristow RG. 2004. Defective DNA strand break repair after DNA damage in prostate cancer cells: Implications for genetic instability and prostate cancer progression. Cancer Res 64:8526-8533. (Pubitemid 39552064)
20. Flygare J, Fält S, Ottervald J, Castro J, Dackland AL, Hellgren D, Wennborg A. 2001. Effects of HsRad51 overexpression on cell proliferation, cell cycle progression, and apoptosis. Exp Cell Res 268:61-69. (Pubitemid 32678860)
21. Francia S, Weiss RS, Hande MP, Freire R, d'Adda di Fagagna F, 2006. Telomere and telomerase modulation by the mammalian Rad9/Rad1/Hus1 DNA-damage-checkpoint complex. Curr Biol 16:1551-1558. (Pubitemid 44142998)
22. Gembka A, Toueille M, Smirnova E, Poltz R, Ferrari E, Villani G, Hübscher U. 2007. The checkpoint clamp, Rad9-Rad1-Hus1 complex, preferentially stimulates the activity of apurinic/apyrimidinic endonuclease 1 and DNA polymerase beta in long patch base excision repair. Nucleic Acids Res 35:2596-2608. (Pubitemid 47073673)
23. Giannattasio M, Lazzaro F, Longhese MP, Plevani P, Muzi-Falconi M. 2004. Physical and functional interactions between nucleotide excision repair and DNA damage checkpoint. EMBO J 23:429-438. (Pubitemid 38294507)
24. Greer DA, Besley BD, Kennedy KB, Davey S. 2003. hRad9 rapidly binds DNA containing double-strand breaks and is required for damage-dependent topoisomerase II beta binding protein 1 focus formation. Cancer Res 63: 4829-4835. (Pubitemid 37022613)
25. Gressner O, Schilling T, Lorenz K, Schulze Schleithoff E, Koch A, Schulze-Bergkamen H, Lena AM, Candi E, Terrinoni A, Catani MV, Oren M, Melino G, Krammer PH, Stremmel W, Müller M, 2005. TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J24:2458-2471. (Pubitemid 41032596)
26. Guan X, Bai H, Shi G, Theriot CA, Hazra TK, Mitra S, Lu AL. 2007a. The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates NEIL1 glycosylase. Nucleic Acids Res 35:2463-2472. (Pubitemid 47073661)
27. Guan X, Madabushi A, Chang DY, Fitzgerald ME, Shi G, Drohat AC, Lu AL. 2007b. The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates DNA repair enzyme TDG glycosylase. Nucleic Acids Res 35:6207-6218. (Pubitemid 350018582)
28. Guervilly JH, Macé-Aimé G, Rosselli F. 2008. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia. Hum Mol Genet 17:679-689. (Pubitemid 351292257)
29. He W, Zhao Y, Zhang C, An L, Hu Z, Liu Y, Han L, Bi L, Xie Z, Xue P, Yang F, Hang H. 2008. Rad9 plays an important role in DNA mismatch repair through physical interaction with MLH1. Nucleic Acids Res 36:6406-6417.
30. He W, Ma X, Yang X, Zhao Y, Qiu J, Hang H. 2011. A role for the arginine methylation of Rad9 in checkpoint control and cellular sensitivity to DNA damage. Nucleic Acids Res 39:4719-4727.
31. Hirai I, Wang HG. 2002. A role of the C-terminal region of human Rad9 (hRad9) in nuclear transport of the hRad9 checkpoint complex. J Biol Chem 277:25722-25727. (Pubitemid 34951892)
32. Hoeijmakers JH. 2001. Genome maintenance mechanisms for preventing cancer. Nature 411:366-374. (Pubitemid 32467046)
33. Hopkins KM, Auerbach W, Wang XY, Hande MP, Hang H, Wolgemuth DJ, Joyner AL, Lieberman HB. 2004. Deletion of mouse rad9 causes abnormal cellular responses to DNA damage, genomic instability, and embryonic lethality. Mol Cell Biol 24:7235-7248. (Pubitemid 39014449)
34. Hu Z, Liu Y, Zhang C, Zhao Y, He W, Han L, Yang L, Hopkins KM, Yang X, Lieberman HB, Hang H. 2008. Targeted deletion of Rad9 in mouse skin keratinocytes enhances genotoxin-induced tumor development. Cancer Res 68:5552-5561.
35. Huang M, Graves LM. 2003. De novo synthesis of pyrimidine nucleotides; emerging interfaces with signal transduction pathways. Cell Mol Life Sci 60:321-336. (Pubitemid 36343912)
36. Ikushima H, Miyazono K. 2010. TGFbeta signalling: A complex web in cancer progression. Nat Rev Cancer 10:415-424.
37. Inagaki A, Sleddens-Linkels E, van Cappellen WA, Hibbert RG, Sixma TK, Hoeijmakers JH, Grootegoed JA, Baarends WM. 2011. Human RAD18 Interacts with Ubiquitylated Chromatin Components and Facilitates RAD9 Recruitment to DNA Double Strand Breaks. PLoS One 6:e23155.
38. Ishikawa K, Ishii H, Murakumo Y, Mimori K, Kobayashi M, Yamamoto K, Mori M, Nishino H, Furukawa Y, Ichimura K. 2007. Rad9 modulates the P21WAF1 pathway by direct association with p53. BMC Mol Biol 8:37.
39. Ishii H, Inageta T, Mimori K, Saito T, Sasaki H, Isobe M, Mori M, Croce CM, Huebner K, Ozawa K, Furukawa Y. 2005. Frag1, a homolog of alternative replication factor C subunits, links replication stress surveillance with apoptosis. Proc Natl Acad Sci USA 102:9655-9660. (Pubitemid 40981736)
40. Jansen JG, Fousteri MI, de Wind N. 2007. Send in the clamps: Control of DNA translesion synthesis in eukaryotes. Mol Cell 28:522-529. (Pubitemid 350137799)
41. Jirawatnotai S, Hu Y, Michowski W, Elias JE, Becks L, Bienvenu F, Zagozdzon A, Goswami T, Wang YE, Clark AB, Kunkel TA, van Harn T, Xia B, Correll M, Quackenbush J, Livingston DM, Gygi SP, Sicinski P. 2011. A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature 474:230-234.
42. Kai M, Furuya K, Paderi F, Carr AM, Wang TS. 2007. Rad3-dependent phosphorylation of the checkpoint clamp regulates repair-pathway choice. Nat Cell Biol 9:691-697. (Pubitemid 47214732)
43. Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A. 2006. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms. World J Surg 30:767-774. (Pubitemid 43724104)
44. Kennedy RD, Gorski JJ, Quinn JE, Stewart GE, James CR, Moore S, Mulligan K, Emberley ED, Lioe TF, Morrison PJ, Mullan PB, Reid G, Johnston PG, Watson PH, Harkin DP. 2005. BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene. Cancer Res 65:10265-10272. (Pubitemid 41743718)
45. Klein HL. 2008. The consequences of Rad51 overexpression for normal and tumor cells. DNA Repair (Amst) 7:686-693.
46. Komatsu K, Miyashita T, Hang H, Hopkins KM, Zheng W, Cuddeback S, Yamada M, Lieberman HB, Wang HG. 2000a. Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis. Nat Cell Biol 2:1-6.
47. Komatsu K, Hopkins KM, Lieberman HB, Wang H. 2000b. Schizosaccharomyces pombe Rad9 contains a BH3-like region and interacts with the antiapoptotic protein Bcl-2. FEBS Lett 481:122-126.
48. Lamber EP, Horwitz AA, Parvin JD. 2010. BRCA1 represses amphiregulin gene expression. Cancer Res 70:996-1005.
49. Lazzaro F, Giannattasio M, Puddu F, Granata M, Pellicioli A, Plevani P, Muzi-Falconi M. 2009. Checkpoint mechanisms at the intersection between DNA damage and repair. DNA Repair (Amst) 8:1055-1067.
50. Lee J, Kumagai A, Dunphy WG. 2007a. The Rad9-Hus1-Rad1 checkpoint clamp regulates interaction of TopBP1 with ATR. J Biol Chem 282:28036-28044. (Pubitemid 47529479)
51. Lee HS, Cho SB, Lee HE, Kim MA, Kim JH, Park do J, Kim JH, Yang HK, Lee BL, Kim WH. 2007b. Protein expression profiling and molecular classification of gastric cancer by the tissue array method. Clin Cancer Res 13:4154-4163. (Pubitemid 47105978)
52. Lee ST, Li Z, Wu Z, Aau M, Guan P, Karuturi RK, Liou YC, Yu Q. 2011. Context-specific regulation of NF-kB target gene expression by EZH2 in breast cancers. Mol Cell 43:798-810.
53. Lieberman HB. 2006. Rad9, an evolutionarily conserved gene with multiple functions for preserving genomic integrity. J Cell Biochem 97:690-697.
54. Lieberman HB, Bernstock JD, Broustas CG, Hopkins KM, Leloup C, Zhu A. 2011. The role of RAD9 in tumorigenesis. J Mol Cell Biol 3:39-43.
55. Lindsey-Boltz LA, Wauson EM, Graves LM, Sancar A. 2004. The human Rad9 checkpoint protein stimulates the carbamoyl phosphate synthetase activity of the multifunctional protein CAD. Nucleic Acids Res 32:4524-4530. (Pubitemid 39317730)
56. Liu K, Paik JC, Wang B, Lin FT, Lin WC. 2006. Regulation of TopBP1 oligomerization by Akt/PKB for cell survival. EMBO J 25:4795-4807. (Pubitemid 44607025)
57. Liu Y, Fang Y, Shao H, Lindsey-Boltz L, Sancar A, Modrich P. 2010. Interactions of human mismatch repair proteins MutSalpha and MutLalpha with proteins of the ATR-Chk1 pathway. J Biol Chem 285:5974-5982.
58. Lönn P, van der Heide LP, Dahl M, Hellman U, Heldin CH, Moustakas A. 2010. PARP-1 attenuates Smad-mediated transcription. Mol Cell 40:521-532.
59. Maniwa Y, Yoshimura M, Bermudez VP, Yuki T, Okada K, Kanomata N, Ohbayashi C, Hayashi Y, Hurwitz J, Okita Y. 2005. Accumulation of hRad9 protein in the nuclei of nonsmall cell lung carcinoma cells. Cancer 103:126-132. (Pubitemid 39665465)
60. Maniwa Y, Yoshimura M, Bermudez VP, Okada K, Kanomata N, Ohbayashi C, Nishimura Y, Hayashi Y, Hurwitz J, Okita Y. 2006. His239Arg SNP of HRAD9 is associated with lung adenocarcinoma. Cancer 106:1117-1122.
61. Mullan PB, Quinn JE, Harkin DP. 2006. The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene 25:5854-5863. (Pubitemid 44453441)
62. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M, Hui CC, Clevers H, Dotto GP, Radtke F. 2003. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33:416-421. (Pubitemid 36278861)
63. Nohmi T, Kim SR, Yamada M. 2005. Modulation of oxidative mutagenesis and carcinogenesis by polymorphic forms of human DNA repair enzymes. Mutat Res 591:60-73. (Pubitemid 41654840)
64. Ormandy CJ, Musgrove EA, Hui R, Daly RJ, Sutherland RL. 2003. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 78:323-335. (Pubitemid 36543212)
65. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, Massagué J. 2008. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133:66-77. (Pubitemid 351442989)
66. Pandita RK, Sharma GG, Laszlo A, Hopkins KM, Davey S, Chakhparonian M, Gupta A, Wellinger RJ, Zhang J, Powell SN, Roti Roti JL, Lieberman HB, Pandita TK, 2006. Mammalian Rad9 plays a role in telomere stability, S-and G2-phase-specific cell survival, and homologous recombinational repair. Mol Cell Biol 26:1850-1864.
67. Paris PL, Andaya A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, Brebner JH, Simko J, Watson JE, Volik S, Albertson DG, Pinkel D, Alers JC, van der Kwast TH, Vissers KJ, Schroder FH, Wildhagen MF, Febbo PG, Chinnaiyan AM, Pienta KJ, Carroll PR, Rubin MA, Collins C, van Dekken H. 2004. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet 13:1303-1313. (Pubitemid 38961638)
68. Paris PL, Sridharan S, Hittelman AB, Kobayashi Y, Perner S, Huang G, Simko J, Carroll P, Rubin MA, Collins C. 2009. An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer. Prostate Cancer Prostatic Dis 12:184-191.
69. Park MJ, Park JH, Hahm SH, Ko SI, Lee YR, Chung JH, Sohn SY, Cho Y, Kang LW, Han YS. 2009. Repair activities of human 8-oxoguanine DNA glycosylase are stimulated by the interaction with human checkpoint sensor Rad9-Rad1-Hus1 complex. DNA Repair (Amst) 8:1190-1200.
70. Polager S, Ginsberg D. 2008. E2F -at the crossroads of life and death. Trends Cell Biol 18:528-535.
71. Roos-Mattjus P, Hopkins KM, Oestreich AJ, Vroman BT, Johnson KL, Naylor S, Lieberman HB, Karnitz LM. 2003. Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signaling. J Biol Chem 278: 24428-24437. (Pubitemid 37548594)
72. Santagata S, Demichelis F, Riva A, Varambally S, Hofer MD, Kutok JL, Kim R, Tang J, Montie JE, Chinnaiyan AM, Rubin MA, Aster JC. 2004. JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res 64:6854-6857. (Pubitemid 39330990)
73. Sherr CJ, Roberts JM. 2004. Living with or without cyclins and cyclindependent kinases. Genes Dev 18:2699-2711. (Pubitemid 39507762)
74. Shou J, Ross S, Koeppen H, de Sauvage FJ, Gao WQ. 2001. Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res 61:7291-7297. (Pubitemid 32951774)
75. Sigoillot FD, Sigoillot SM, Guy HI. 2004. Breakdown of the regulatory control of pyrimidine biosynthesis in human breast cancer cells. Int J Cancer 109: 491-498. (Pubitemid 38339638)
76. Smirnova E, Toueille M, Markkanen E, Hübscher U. 2005. The human checkpoint sensor and alternative DNA clamp Rad9-Rad1-Hus1 modulates the activity of DNA ligase I, a component of the long-patch base excision repair machinery. Biochem J 389:13-17. (Pubitemid 40978002)
77. St Onge RP, Besley BD, Park M, Casselman R, Davey S. 2001. DNA damagedependent and -independent phosphorylation of the hRad9 checkpoint protein. J Biol Chem 276:41898-41905.
78. St Onge RP, Besley BD, Pelley JL, Davey S. 2003. A role for the phosphorylation of hRad9 in checkpoint signaling. J Biol Chem 278:26620-26628. (Pubitemid 36876807)
79. Sunavala-Dossabhoy G, De Benedetti A. 2009. Tousled homolog, TLK1, binds and phosphorylates Rad9; TLK1 acts as a molecular chaperone in DNA repair. DNA Repair (Amst) 8:87-102.
80. Takahashi A, Tsutsumi R, Kikuchi I, Obuse C, Saito Y, Seidi A, Karisch R, Fernandez M, Cho T, Ohnishi N, Rozenblatt-Rosen O, Meyerson M, Neel BG, Hatakeyama M. 2011. SHP2 tyrosine phosphatase converts parafibromin/ Cdc73 from a tumor suppressor to an oncogenic driver. Mol Cell 43:45-56.
81. Takeishi Y, Ohashi E, Ogawa K, Masai H, Obuse C, Tsurimoto T. 2010. Casein kinase 2-dependent phosphorylation of human Rad9 mediates the interaction between human Rad9-Hus1-Rad1 complex and TopBP1. Genes Cells 15:761-771.
82. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454.
83. Toueille M, El-Andaloussi N, Frouin I, Freire R, Funk D, Shevelev I, Friedrich-Heineken E, Villani G, Hottiger MO, Hübscher U. 2004. The human Rad9/ Rad1/Hus1 damage sensor clamp interacts with DNA polymerase beta and increases its DNA substrate utilisation efficiency: Implications for DNA repair. Nucleic Acids Res 32:3316-3324. (Pubitemid 39117448)
84. Volkmer E, Karnitz LM. 1999. Human homologs of Schizosaccharomyces pombe rad1, hus1, and rad9 form a DNA damage-responsive protein complex. J Biol Chem 274:567-570.
85. Wang W, Brandt P, Rossi ML, Lindsey-Boltz L, Podust V, Fanning E, Sancar A, Bambara RA. 2004. The human Rad9-Rad1-Hus1 checkpoint complex stimulates flap endonuclease 1. Proc Natl Acad Sci USA 101: 16762-1677.
86. Wang W, Lindsey-Boltz LA, Sancar A, Bambara RA. 2006. Mechanism of stimulation of human DNA ligase I by the Rad9-rad1-Hus1 checkpoint complex. J Biol Chem 281:20865-20872. (Pubitemid 44115427)
87. Wang Z, Li Y, Banerjee S, Kong D, Ahmad A, Nogueira V, Hay N, Sarkar FH. 2010. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. J Cell Biochem 109:726-736.
88. Warmerdam DO, Freire R, Kanaar R, Smits VA. 2009. Cell cycle-dependent processing of DNA lesions controls localization of Rad9 to sites of genotoxic stress. Cell Cycle 8:1765-1774.
89. Wilson KA, Colavito SA, Schulz V, Wakefield PH, Sessa W, Tuck D, Stern DF. 2011. NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53. Mol Cancer Res 9:766-781.
90. Wu X, Shell SM, Zou Y. 2005. Interaction and colocalization of Rad9/Rad1/ Hus1 checkpoint complex with replication protein A in human cells. Oncogene 24:4728-4735. (Pubitemid 41032609)
91. Xu X, Vaithiyalingam S, Glick GG, Mordes DA, Chazin WJ, Cortez D. 2008. The basic cleft of RPA70N binds multiple checkpoint proteins, including RAD9, to regulate ATR signaling. Mol Cell Biol 28:7345-7353.
92. Yin Y, Zhu A, Jin YJ, Liu YX, Zhang X, Hopkins KM, Lieberman HB. 2004. Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21. Proc Natl Acad Sci USA 101:8864-8869. (Pubitemid 38781577)
93. Yoshida K, Komatsu K, Wang HG, Kufe D. 2002. c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage. Mol Cell Biol 22:3292-3300. (Pubitemid 34453971)
94. Yoshida K, Wang HG, Miki Y, Kufe D. 2003. Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9. EMBO J 22:1431-1441. (Pubitemid 36362706)
95. Yuki T, Maniwa Y, Doi T, Okada K, Nishio W, Hayashi Y, Okita Y. 2008. DNA damage sensor protein hRad9, a novel molecular target for lung cancer treatment. Oncol Rep 20:1047-1052.
96. Zachos G, Rainey MD, Gillespie DA. 2003. Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects. EMBO J 22:713-723. (Pubitemid 36193615)
97. Zheng L, Jia J, Finger LD, Guo Z, Zer C, Shen B. 2011. Functional regulation of FEN1 nuclease and its link to cancer. Nucleic Acids Res 39:781-794.
98. Zhu A, Zhou H, Leloup C, Marino SA, Geard CR, Hei TK, Lieberman HB. 2005. Differential impact of mouse Rad9 deletion on ionizing radiation-induced bystander effects. Radiat Res 164:655-661. (Pubitemid 41532561)
99. Zhu A, Zhang CX, Lieberman HB. 2008. Rad9 has a functional role in human prostate carcinogenesis. Cancer Res 68:1267-1274. (Pubitemid 351346832)